Suspension of trading
Quotes Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0135 USD | -3.57% |
|
-10.00% | -99.91% |
| 13/24/13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 07/24/07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Performance
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% | ||
| 1 year | -99.92% | ||
| 3 years | -99.98% | ||
| 5 years | -100.00% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
16,768
Free-Float
99.33 %
Free-Float capitalization (USD)
16,660
Indicators
Moving average 5 days
0.0159
Moving average 100 days
0.5599
Price spread / (MMA5)
+17.78%
Price spread / (MMA100)
+4,047.41%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.57% | -10.00% | -99.92% | -99.98% | 16.77T | ||
| +1.03% | +2.30% | +55.91% | +114.22% | 5.64TCr | ||
| +2.72% | +3.26% | +46.05% | +44.91% | 4.45TCr | ||
| +1.12% | +2.79% | -15.04% | -21.68% | 2.29TCr | ||
| +1.17% | +3.85% | -0.89% | +403.86% | 2.12TCr | ||
| +3.81% | -5.07% | +11.00% | -30.62% | 1.64TCr | ||
| +0.15% | +2.24% | +9.32% | -39.30% | 1.54TCr | ||
| -0.69% | +0.82% | +27.75% | +176.72% | 1.34TCr | ||
| +5.27% | +5.54% | +19.65% | - | 1.24TCr | ||
| +1.61% | +1.28% | +95.75% | +205.26% | 1.12TCr | ||
| Average | +1.80% | +2.09% | +14.96% | +83.71% | 2.14TCr | |
| Weighted average by Cap. | +1.72% | +2.37% | +32.04% | +99.59% |
Historical Quotes: Acorda Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.01 | 0.02 | |
| 1 month | 0.01 | 0.15 | |
| 3 years | 0.01 | 99.8 | |
| 5 years | 0.01 | 535.2 |
Monthly variations
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
- Quotes Acorda Therapeutics
Select your edition
All financial news and data tailored to specific country editions
















